seed
Stage
1
Investors
About
Synvivia develops engineered molecules designed to reprogram cells for therapeutic applications.
Explore Synvivia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
Synvivia develops engineered molecules designed to reprogram cells for therapeutic applications.
Funding rounds, investor list, and risk signals — unlock with a subscription.